SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-16-000045
Filing Date
2016-05-04
Accepted
2016-05-04 17:26:18
Documents
56
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a03311610-q.htm 10-Q 1101508
2 EXHIBIT 31.1 a03312016ex311.htm EX-31.1 14779
3 EXHIBIT 31.2 a03312016ex312.htm EX-31.2 14048
4 EXHIBIT 32.1 a03312016ex321.htm EX-32.1 11782
  Complete submission text file 0001100412-16-000045.txt   5965583

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20160331.xml EX-101.INS 1303975
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20160331.xsd EX-101.SCH 37999
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20160331_cal.xml EX-101.CAL 61810
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20160331_def.xml EX-101.DEF 228680
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20160331_lab.xml EX-101.LAB 591901
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20160331_pre.xml EX-101.PRE 356947
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 161620645
SIC: 2834 Pharmaceutical Preparations